DGX

259.4650.14%
SA

Sam A. Samad

Independent Director

Mr. Sam A. Samad has been an Executive Vice President of Quest Diagnostics Incorporated since July 11, 2022 and has been its Chief Financial Officer since July 25, 2022. He joined Quest Diagnostics Incorporated on July 11, 2022. He is responsible for the Quest Diagnostics Incorporated's finance, accounting, investor relations, internal audit and treasury activities. He had been Chief Financial Officer at Illumina, Inc. since January 6, 2017 and served as its Senior Vice President since January 6, 2017 until 2021. He served as a Senior Vice President and Treasurer of Cardinal Health, Inc. until January 2017 and held several senior leadership positions with leadership responsibility for Cardinal Health's China business. He served as Senior Vice President and Chief Financial Officer for the pharmaceutical segment and Vice President of Healthcare Supply Chain Services. He has been Independent Director of IDEXX Laboratories, Inc since July 16, 2019. He also previously held sales and finance roles at Eli Lilly and Company, both domestically and internationally and PepsiCo Inc. Mr. Samad holds a BBA degree from the American University of Beirut in Lebanon and an MBA from McMaster University in Hamilton, Canada.

Positions